I don't look at this thread very often. Mainly because I see it as a minimal 3 year proposition, I also feel things are moving in the right direction. So no real fears there. [Apart from the cash burn]
However, I think it's difficult not to acknowledge that the remuneration packages particularly for the CEO are pretty generous. I also wonder why such a large executive team at this stage of the companies development.
But a good read out at the end of the Glioblastoma trial later this year may just give the sp a leg up. Then there is the question of funding for a Phase 2 ?
So happy to hold and see what happens.
I don't look at this thread very often. Mainly because I see it...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $12.99M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $949 | 312.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 70 | 67782438 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 91927011 | 27 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| CHM (ASX) Chart |